CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging.

@article{Piva2000CEAMI,
  title={CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging.},
  author={Maria Grazia Piva and Filippo Navaglia and Daniela Basso and Paola Fogar and Giovanni Roveroni and Nicoletta Gallo and C F Zambon and Sergio Pedrazzoli and Mario Plebani},
  journal={Oncology},
  year={2000},
  volume={59 4},
  pages={323-8}
}
OBJECTIVE It has been suggested that the molecular identification of cancer cells in the circulation may be useful in predicting the presence of micrometastasis in several cancer types. The aim of the present study was therefore to assess the feasibility of CEA mRNA identification in blood for diagnosing and staging colorectal, gastric and pancreatic cancer. METHODS We studied 16 control subjects, 69 patients with colorectal (CRC), 30 with gastric (GC), 27 with pancreatic cancer (PC) and 8… CONTINUE READING